Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Clinical trial NCT00363883 · TERMINATED

Trial details

NCT number: NCT00363883
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Localized Transitional Cell Cancer of the Renal Pelvis and Ureter Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Transitional Cell Carcinoma of the Bladder

Start date: 2006-06-01
Primary completion: 2010-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.